• piecat@lemmy.world
        link
        fedilink
        English
        arrow-up
        22
        ·
        1 year ago

        There is some level of R&D they do to productize it, manufacturability and scaling. And running drug safety trials cannot be cheap, especially the liability insurance.

        That all said, I think it’s criminal that the university labs pay so little. PhD students barely make over $40k, set by the NIH. Not adjusted for CoL either.

        I think I have more of an issue with the for-profit nature of pharma companies. Shareholders shouldn’t be involved in medicine.

    • uis@lemmy.world
      link
      fedilink
      English
      arrow-up
      6
      ·
      edit-2
      1 year ago

      AFAIK some US agency did R&D for COVID, they just bribed sponsored Right People